SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-031573
Filing Date
2021-12-15
Accepted
2021-12-15 16:15:16
Documents
12
Period of Report
2021-12-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40508
  Complete submission text file 0001493152-21-031573.txt   219208

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE glsi-20211215.xsd EX-101.SCH 3064
3 XBRL LABEL FILE glsi-20211215_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE glsi-20211215_pre.xml EX-101.PRE 22815
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3876
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 211494366
SIC: 2834 Pharmaceutical Preparations